Pretargeted Radioimmunotherapy with the Novel Anti-oxMIF/HSG Bispecific Antibody ON105 Results in Significant Tumor Regression in Murine Models of Cancer

ABSTRACT:

SUBMITTER:  

PROVIDER: S-EPMC11372362 | biostudies-literature | 2024 Jul

REPOSITORIES: biostudies-literature